In a 52-year-old male chronic alcoholic presenting with two days of hematemesis, currently no active bleeding, blood pressure 110/70 mmHg and tachycardia 134 bpm, what is the likely diagnosis and appropriate treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis and Treatment

This is a clinically significant variceal hemorrhage from esophagogastric varices secondary to alcoholic cirrhosis, and immediate management requires resuscitation, vasoactive drugs, antibiotics, and urgent endoscopy within 12 hours.

Diagnosis

The presentation is highly consistent with acute variceal bleeding in the context of alcoholic liver disease. Despite the absence of active hematemesis today, this patient meets criteria for clinically significant variceal hemorrhage based on:

  • Tachycardia (134 bpm) - pulse rate >100 bpm at presentation 1
  • Recent hematemesis (2 days of blood vomiting)
  • Known chronic alcoholism - the primary risk factor for cirrhosis and portal hypertension
  • Relatively maintained blood pressure (110/70 mmHg) - though this is borderline and the tachycardia indicates compensated shock

The tachycardia is a critical finding. While alcohol withdrawal syndrome can also cause tachycardia 2, the recent hematemesis makes variceal bleeding the primary concern requiring immediate intervention. The blood pressure, though appearing "normal," combined with marked tachycardia indicates ongoing hypovolemia and compensatory mechanisms.

Immediate Treatment Algorithm

1. Resuscitation (First Priority)

  • Restrictive transfusion strategy: Transfuse packed red blood cells only if hemoglobin ≤70 g/L, targeting post-transfusion hemoglobin of 70-90 g/L 3
  • Avoid aggressive fluid resuscitation: Target systolic BP of 90 mmHg for the first hour (hypotensive resuscitation principles) 4
  • Secure IV access and obtain urgent labs (CBC, coagulation profile, liver function tests, renal function)

2. Pharmacological Therapy (Start Immediately)

Before endoscopy, initiate:

  • Vasoactive agents (choose one):

    • Terlipressin, octreotide, or somatostatin
    • Continue for up to 5 days 3
  • Antibiotic prophylaxis:

    • Ceftriaxone 1g IV daily for up to 7 days 3
    • This reduces mortality and prevents spontaneous bacterial peritonitis
  • Proton pump inhibitor (PPI):

    • High-dose IV PPI should be given 4
  • Erythromycin 250mg IV:

    • Give 30-120 minutes before endoscopy to improve visualization 3

3. Urgent Endoscopy

  • Perform within 12 hours of presentation after hemodynamic resuscitation 3
  • Endoscopic band ligation (EBL) is the treatment of choice for esophageal varices 3
  • If gastric varices (GOV2, IGV1) are found, use cyanoacrylate injection 3

4. Risk Stratification

Calculate:

  • Child-Pugh score
  • MELD score

If high-risk features present (Child-Pugh C ≤13 or Child-Pugh B >7 with active bleeding despite vasoactive agents):

  • Consider pre-emptive TIPS within 72 hours (preferably within 24 hours) 3

5. Monitor for Alcohol Withdrawal

Given the alcoholic history and tachycardia:

  • Use CIWA-Ar score to assess for alcohol withdrawal syndrome 5
  • If CIWA-Ar >8: Start benzodiazepines
    • Use lorazepam or oxazepam (safer in hepatic dysfunction) rather than long-acting benzodiazepines 5
    • Avoid fixed-dose schedules; use symptom-triggered regimens 5

Critical Pitfalls to Avoid

  1. Do NOT over-transfuse: Aggressive transfusion increases portal pressure and rebleeding risk. Target hemoglobin 70-90 g/L 3

  2. Do NOT delay vasoactive drugs: Start immediately upon presentation, before endoscopy confirmation 3

  3. Do NOT use long-acting benzodiazepines (diazepam, chlordiazepoxide) if withdrawal treatment needed - use lorazepam or oxazepam due to liver disease 5

  4. Do NOT delay endoscopy beyond 12 hours once hemodynamically stable 3

  5. Do NOT forget antibiotics: Ceftriaxone prophylaxis is mandatory and reduces mortality 3

Secondary Prevention (After Acute Episode)

  • Repeat EBL every 1-4 weeks until variceal eradication 3
  • Start non-selective beta blocker (preferably carvedilol) in combination with endoscopic therapy 3
  • Surveillance endoscopy every 3-6 months in first year after eradication 3

Definitive Management Consideration

If refractory bleeding or high-risk features:

  • TIPS placement (transjugular intrahepatic portosystemic shunt) 3, 6
  • Liver transplantation evaluation - offers best long-term survival 6

Related Questions

What is the recommended management for perisplenic varices associated with portal hypertension?
In a 35-year-old patient with chronic liver disease and portal hypertension, a splenectomy performed five years ago, small esophageal varices, and a history of recurrent altered sensorium, now presenting with grade 4 hepatic encephalopathy, what is the appropriate management?
What medication can be prescribed for nausea and vomiting in a patient with cirrhosis, portal hypertension, and esophageal varices?
What are the causes of esophageal varices other than portal hypertension?
In a 52-year-old man with chronic liver disease and esophageal varices presenting with fever, altered mental status, markedly elevated procalcitonin, high C-reactive protein, moderately elevated erythrocyte sedimentation rate, leukocytosis with neutrophil predominance, thrombocytopenia, elevated D-dimer, and normal bilirubin and renal function, what are the differential diagnoses and recommended management?
How is abetalipoproteinemia diagnosed and managed?
What is the recommended dosing and administration protocol for a continuous intravenous infusion of atracurium (non‑depolarizing neuromuscular blocker)?
What is the likely diagnosis and recommended treatment for a patient with anemia, leukopenia, a normal platelet count, and an abnormal Widal test?
In a 33‑year‑old female with nausea, prior cholecystectomy, mildly elevated serum lipase and amylase, normal liver function tests, and positive CMV IgM with high‑avidity IgG and EBV IgM/IgG, should semaglutide (Wegovy) be discontinued and how should a presumed mild acute pancreatitis be managed?
What is the amount of elemental calcium in a calcium gluconate solution?
What is the recommended management of fibro‑adipose vascular anomaly (FAVA) lesions that are classified as slow‑flow malformations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.